AAAAAA

   
Results: 1-25 | 26-40
Results: 1-25/40
P53 MUTATIONS IN CYCLOPHOSPHAMIDE-ASSOCIATED BLADDER-CANCER
Authors: KHAN MA TRAVIS LB LYNCH CF SOINI Y HRUSZKEWYCZ AM DELGADO RM HOLOWATY EJ VANLEEUWEN FE GLIMELIUS B STOVALL M BOICE JD TARONE RE BENNETT WP
Citation: Ma. Khan et al., P53 MUTATIONS IN CYCLOPHOSPHAMIDE-ASSOCIATED BLADDER-CANCER, Cancer epidemiology, biomarkers & prevention, 7(5), 1998, pp. 397-403
WORSE SURVIVAL OF PATIENTS WITH ENDOMETRIAL CANCER FOLLOWING TAMOXIFEN TREATMENT FOR BREAST-CANCER - A STUDY WITH 309 2ND TUMORS
Authors: BERGMAN L BEELEN MLR GALLEE MPW BENRAADT J VANLEEUWEN FE
Citation: L. Bergman et al., WORSE SURVIVAL OF PATIENTS WITH ENDOMETRIAL CANCER FOLLOWING TAMOXIFEN TREATMENT FOR BREAST-CANCER - A STUDY WITH 309 2ND TUMORS, European journal of cancer, 34, 1998, pp. 99-99
LONG-TERM RISK OF SOLID TUMORS IN SURVIVORS OF HODGKINS-DISEASE
Authors: VANLEEUWEN FE KLOKMAN WJ HAGENBEEK A VANTVEER MB BAARS JW ALEMAN BMP RUSSELL NS SOMERS R
Citation: Fe. Vanleeuwen et al., LONG-TERM RISK OF SOLID TUMORS IN SURVIVORS OF HODGKINS-DISEASE, British Journal of Haematology, 102(1), 1998, pp. 271-271
P53 PROTEIN OVEREXPRESSION IN RELATION TO RISK-FACTORS FOR BREAST-CANCER - REPLY
Authors: VANDERKOOY K ROOKUS MA PETERSE HL VANLEEUWEN FE
Citation: K. Vanderkooy et al., P53 PROTEIN OVEREXPRESSION IN RELATION TO RISK-FACTORS FOR BREAST-CANCER - REPLY, American journal of epidemiology, 147(5), 1998, pp. 512-512
THE EFFECT OF TAMOXIFEN ON THE RISK AND PROGNOSIS OF ENDOMETRIAL CANCER FOLLOWING BREAST-CANCER
Authors: VANLEEUWEN FE BERGMAN L BEELEN MLR GALLEE MPW BENRAADT J
Citation: Fe. Vanleeuwen et al., THE EFFECT OF TAMOXIFEN ON THE RISK AND PROGNOSIS OF ENDOMETRIAL CANCER FOLLOWING BREAST-CANCER, American journal of epidemiology, 147(11), 1998, pp. 256-256
INDUCED-ABORTION AND RISK FOR BREAST-CANCER - REPORTING (RECALL) BIASIN A DUTCH CASE-CONTROL STUDY
Authors: ROOKUS MA VANLEEUWEN FE
Citation: Ma. Rookus et Fe. Vanleeuwen, INDUCED-ABORTION AND RISK FOR BREAST-CANCER - REPORTING (RECALL) BIASIN A DUTCH CASE-CONTROL STUDY, Journal of the National Cancer Institute, 89(8), 1997, pp. 589-590
RISK OF 2ND MALIGNANT NEOPLASMS AMONG LONG-TERM SURVIVORS OF TESTICULAR CANCER
Authors: TRAVIS LB CURTIS RE STORM H HALL P HOLOWATY E VANLEEUWEN FE KOHLER BA PUKKALA E LYNCH CF ANDERSSON M BERGFELDT K CLARKE EA WIKLUND T STOTER G GOSPODAROWICZ M STURGEON J FRAUMENI JF BOICE JD
Citation: Lb. Travis et al., RISK OF 2ND MALIGNANT NEOPLASMS AMONG LONG-TERM SURVIVORS OF TESTICULAR CANCER, Journal of the National Cancer Institute, 89(19), 1997, pp. 1429-1439
BREAST-CANCER AND HORMONE REPLACEMENT THERAPY - COLLABORATIVE REANALYSIS OF DATA FROM 51 EPIDEMIOLOGIC STUDIES OF 52,705 WOMEN WITH BREAST-CANCER AND 108,411 WOMEN WITHOUT BREAST-CANCER
Authors: BERAL V BULL D DOLL R KEY T PETO R REEVES G CALLE EE HEATH CW COATES RJ LIFF JM FRANCESCHI S TALAMINI R CHANTARAKUL N KOETSAWANG S RACHAWAT D MORABIA A SCHUMAN L STEWART W SZKLO M BAIN C SCHOFIELD F SISKIND V BAND P COLDMAN AJ GALLAGHER RP HISLOP TG YANG P DUFFY SW KOLONEL LM NOMURA AMY OBERLE MW ORY HW PETERSON HB WILSON HG WINGO PA EBELING K KUNDE D NISHAN P COLDITZ G MARTIN N PARDTHAISONG T SILPISORNKOSOL S THEETRANONT C BOOSIRI B CHUTIVONGSE S JIMAKORN P VIRUTAMASEN P WONGSRICHANALAI C MCMICHAEL AJ ROHAN T EWERTZ M ADAMI HO BERGKVIST R PERSSON I PAUL C SKEGG DCG SPEARS GFS BOYLE P EVSTIFEEVA T DALING JR HUTCHINSON WB MALONE K NOONAN EA STANFORD JL THOMAS DB WEISS NS WHITE E ANDRIEU N BRAMOND A CLAVEL F GAIRARD B LANSAC J PIANA L RENAUD R FINE SRP CUEVAS HR ONTIVEROS P PALET A SALAZAR SB ARISTIZABAL N CUADROS A BACHELOR A LE MG DEACON J PETO J TAYLOR CN MODAN B RON E FRIEDMAN GD HIATT RA LEVI F BISHOP T KOSMELJ K PRIMICZAKELJ M RAVNIHAR B STARE J BEESON WL FRASER G BULBROOK RD CUZICK J FENTIMAN IS HAYWARD JL WANG DY MCPHERSON K HANSON RL LESKE MC MAHONEY MC NASCA PC VARMA AO WEINSTEIN AL MOLLER TR OLSSON H RANSTAM J GOLDBOHM RA VANDENBRANDT PA APELO RA BAENS J DELACRUZ JR JAVIER B LACAYA LB NGELANGEL CA LAVECCHIA C NEGRI E MARUBINI E FERRARONI M GERBER M RICHARDSON S SEGALA C GATEI D KENYA P KUNGU A MATI JG BRINTON LA HOOVER R SCHAIRER C SPIRTAS R LEE HP ROOKUS MA VANLEEUWEN FE SCHOENBERG JA GAMMON MD CLARKE EA JONES L NEIL A VESSEY M YEATES D CROSSLEY B HERMON C JONES S LEWIS C COLLINS R MABUCHI K PRESTON D HANNAFORD P KAY C ROSEROBIXBY L YUAN JM WEI HY YUN T ZHIHENG C BERRY G BOOTH JC JELIHOVSKY T MACLENNAN R SHEARMAN R WANG QS BAINES CJ MILLER AB WALL C LUND E STALSBERG H KATSOUYANNI K TRICHOPOULOU A DABANCENS A MARTINEZ L MOLINA R SALAS O ALEXANDER FE FOLSOM AR CHILVERS CED BERNSTEIN L HAILE RW PAGANINIHILL A PIKE MC ROSS RK URSIN G YU MC LONGNECKER MP NEWCOMB P BERGKVIST L FARLEY TMN HOLCK S MEIRIK O
Citation: V. Beral et al., BREAST-CANCER AND HORMONE REPLACEMENT THERAPY - COLLABORATIVE REANALYSIS OF DATA FROM 51 EPIDEMIOLOGIC STUDIES OF 52,705 WOMEN WITH BREAST-CANCER AND 108,411 WOMEN WITHOUT BREAST-CANCER, Lancet, 350(9084), 1997, pp. 1047-1059
SMOKING AND BREAST-CANCER RISK
Authors: VANLEEUWEN FE DEVRIES F VANDERKOOY K ROOKUS M
Citation: Fe. Vanleeuwen et al., SMOKING AND BREAST-CANCER RISK, American journal of epidemiology, 145(11), 1997, pp. 115-115
SMOKING, TREATMENT FOR HODGKINS-DISEASE, AND SUBSEQUENT LUNG-CANCER RISK
Authors: VANLEEUWEN FE KLOKMAN WJ
Citation: Fe. Vanleeuwen et Wj. Klokman, SMOKING, TREATMENT FOR HODGKINS-DISEASE, AND SUBSEQUENT LUNG-CANCER RISK, Journal of the National Cancer Institute, 88(3-4), 1996, pp. 209-209
INDUCED-ABORTION AND RISK FOR BREAST-CANCER - REPORTING (RECALL) BIASIN A DUTCH CASE-CONTROL STUDY
Authors: ROOKUS MA VANLEEUWEN FE
Citation: Ma. Rookus et Fe. Vanleeuwen, INDUCED-ABORTION AND RISK FOR BREAST-CANCER - REPORTING (RECALL) BIASIN A DUTCH CASE-CONTROL STUDY, Journal of the National Cancer Institute, 88(23), 1996, pp. 1759-1764
P53 MUTATIONS IN LUNG-CANCER FOLLOWING RADIATION-THERAPY FOR HODGKINS-DISEASE
Authors: DEBENEDETTI VMG TRAVIS LB WELSH JA VANLEEUWEN FE STOVALL M CLARKE EA BOICE JD BENNETT WP
Citation: Vmg. Debenedetti et al., P53 MUTATIONS IN LUNG-CANCER FOLLOWING RADIATION-THERAPY FOR HODGKINS-DISEASE, Cancer epidemiology, biomarkers & prevention, 5(2), 1996, pp. 93-98
RISK OF ACUTE MYELOGENOUS LEUKEMIA AND MYELODYSPLASIA FOLLOWING CANCER-TREATMENT
Authors: VANLEEUWEN FE
Citation: Fe. Vanleeuwen, RISK OF ACUTE MYELOGENOUS LEUKEMIA AND MYELODYSPLASIA FOLLOWING CANCER-TREATMENT, Bailliere's clinical haematology, 9(1), 1996, pp. 57-85
TAMOXIFEN, BALANCING RISKS AND BENEFITS
Authors: BERGMAN L BENRAADT J VANLEEUWEN FE
Citation: L. Bergman et al., TAMOXIFEN, BALANCING RISKS AND BENEFITS, Netherlands journal of medicine, 49(6), 1996, pp. 228-234
BREAST-CANCER AND HORMONAL CONTRACEPTIVES - COLLABORATIVE REANALYSIS OF INDIVIDUAL DATA ON 53297 WOMEN WITH BREAST-CANCER AND 100239 WOMEN WITHOUT BREAST-CANCER FROM 54 EPIDEMIOLOGIC STUDIES
Authors: CALLE EE HEATH CW MIRACLEMCMAHILL HL COATES RJ LIFF JM FRANCESCHI S TALAMINI R CHANTARAKUL N KOETSAWANG S RACHAWAT D MORABIA A SCHUMAN L STEWART W SZKLO M BAIN C SCHOFIELD F SISKIND V BAND P COLDMAN AJ GALLAGHER RP HISLOP TG YANG P DUFFY SW KOLONEL LM NOMURA AMY OBERLE MW ORY HW PETERSON HB WILSON HG WINGO PA EBELING K KUNDE D NISHAN P COLDITZ G MARTIN N PARDTHAISONG T SILPISORNKOSOL S THEETRANONT C BOOSIRI B CHUTIVONGSE S JIMAKORN P VIRUTAMASEN P WONGSRICHANALAI C MCMICHAEL AJ ROHAN T EWERTZ M PAUL C SKEGG DCG BOYLE P EVSTIFEEVA M DALING JR MALONE K NOONAN EA STANFORD JL THOMAS DB WEISS NS WHITE E ANDRIEU N BREMOND A CLAVEL F GAIRARD B LANSAC J PIANA L RENAUD R CUEVAS HR ONTIVEROS P PALET A SALAZAR SB ARISTIZABEL N CUADROS A BACHELOT A LE MG DEACON J PETO J TAYLOR CN ALFANDARY E MODAN B RON E FRIEDMAN GD HIATT RA BISHOP T KOSMELJ J PRIMICZAKELJ M RAVNIHAR B STARE J BEESON WL FRASER G ALLEN DS BULBROOK RD CUZICK J FENTIMAN IS HAYWARD JL WANG DY HANSON RL LESKE MC MAHONEY MC NASCA PC VARMA AO WEINSTEIN AL MOLLER TR OLSSON H RANSTAM J GOLDBOHM RA VANDENBRANDT PA APELO RA BAENS J DELACRUZ JR JAVIER B LACAYA LB NGELANGEL CA LAVECCHIA C NEGRI E MARUBINI E FERRARONI M GERBER M RICHARDSON S SEGALA C GATEI D KENYA P KUNGU A MATI JG BRINTON LA HOOVER R SCHAIRER C SPIRTAS R LEE HP ROOKUS MA VANLEEUWEN FE SCHOENBERG JA GAMMON MD CLARKE EA JONES L MCPHERSON K NEIL A VESSEY M YEATES D BERAL V BULL D CROSSLEY B HERMON C JONES S KEY T LEWIS C REEVES G SMITH P COLLINS R DOLL R PETO R HANNAFORD P KAY C ROSEROBIXBY L GAO YT YUAN JM WEI HY YUN T ZHIHENG C BERRY G BOOTH JC JELIHOVSKY T MACLENNAN R SHEARMAN R WANG QS BAINES CJ MILLER AB WALL C LUND E STALSBERG H DABANCENS A MARTINEZ L MOLINA R SALAS O ALEXANDER FE HULKA BS BERNSTEIN L HAILE RW PAGANINIHILL A PIKE MC ROSS RK URSIN G YU MC ADAMI HO BERGSTROM R LONGNECKER MP NEWCOMB P FARLEY TMN HOLCK S MEIRIK O
Citation: Ee. Calle et al., BREAST-CANCER AND HORMONAL CONTRACEPTIVES - COLLABORATIVE REANALYSIS OF INDIVIDUAL DATA ON 53297 WOMEN WITH BREAST-CANCER AND 100239 WOMEN WITHOUT BREAST-CANCER FROM 54 EPIDEMIOLOGIC STUDIES, Lancet, 347(9017), 1996, pp. 1713-1727
BREAST-CANCER AND HORMONAL CONTRACEPTIVES - FURTHER RESULTS
Authors: CALLE EE HEATH CW MIRACLEMCMAHILL HL COATES RJ LIFF JM FRANCESCHI S TALAMINI R CHANTARAKUL N KOETSAWANG S RACHAWAT D MORABIA A SCHUMAN I STEWART W SZKLO M BAIN C SCHOFIELD F SISKIND V BAND P COLDMAN AJ GALLAGHER RP HISLOP TG YANG P DUFFY SW KOLONEL LM NOMURA AMY OBERLE MW ORY HW PETERSON HB WILSON HG WINGO PA EBELING K KUNDE D NISHAN P COLDITZ G MARTIN N PARDTHAISONG T SILPISORNKOSOL S THEETRANONT C BOOSIRI B CHUTIVONGSE S JIMAKORN P VIRUTAMASEN P WONGSRICHANALAI C MCMICHAEL AJ ROHAN T EWERTZ M PAUL C SKEGG DCG SPEARS GFS BOYLE P EVSTIFEEVA T DALING JR MALONE K NOONAN EA STANFORD JL THOMAS DB WEISS NS WHITE E ANDRIEU N BREMOND A CLAVEL F GAIRARD B LANSAC J PIANA L RENAUD R FINE SRP CUEVAS HR ONTIVEROS P PALET A SALAZAR SB ARISTIZABEL N CUADROS A BACHELOT A LE MG DEACON J PETO J TAYLOR CN ALFANDARY E MODAN B RON E FRIEDMAN GD HIATT RA BISHOP T KOSMELJ K PRIMICZAKELJ M RAVNIHAR B STARE J BEESON WL FRASER G ALLEN DS BULBROOK RD CUZICK J FENTIMAN IS HAYWARD JL WANG DY HANSON RL LESKE MC MAHONEY MC NASCA PC VARMA AP WEINSTEIN AL MOLLER TR OLSSON H RANSTAM J GOLDBOHM RA VANDENBRANDT PA APELO RA BAENS J DELACRUZ JR JAVIER B LACAYA LB NGELANGEL CA LAVECCHIA C NEGRI E MARBUNI E FERRARONI M GERBER M RICHARDSON S SEGALA C GATEI D KENYA P KUNGU A MATI JG BRINTON LA HOOVER R SCHAIRER C SPIRTAS R LEE HP ROOKUS MA VANLEEUWEN FE SCHOENBERG JA GAMMON MD CLARKE EA JONES L MCPHERSON K NEIL A VESSEY M YEATES D BERAL V BULL D CROSSLEY B HERMON C JONES S KEY T LEWIS C REEVES G SMITH P COLLINS R DOLL R PETO R HANNAFORD P KAY C ROSEROBIXBY L YUAN JM WEI HY YUN T ZHIHENG C BERRY G BOOTH JC JELIHOVSKY T MACLENNAN R SHEARMAN R WANG QS BAINES CJ MILLER AB WALL C LUND E STALSBERG H DABANCENS A MARTINEZ L MOLINA R SALAS O ALEXANDER FE HULKA BS CHILVERS CED BERNSTEIN L HAILE RW PAGANINIHILL A PIKE MC ROSS RK URSIN G YU MC ADAMI HO BERGSTROM R LONGNECKER MP NEWCOMB P FARLEY TMN HOLCK S MEIRIK O
Citation: Ee. Calle et al., BREAST-CANCER AND HORMONAL CONTRACEPTIVES - FURTHER RESULTS, Contraception, 54(3), 1996, pp. 1-106
P53 PROTEIN OVEREXPRESSION IN RELATION TO RISK-FACTORS FOR BREAST-CANCER
Authors: VANDERKOOY K ROOKUS MA PETERSE HL VANLEEUWEN FE
Citation: K. Vanderkooy et al., P53 PROTEIN OVEREXPRESSION IN RELATION TO RISK-FACTORS FOR BREAST-CANCER, American journal of epidemiology, 144(10), 1996, pp. 924-933
BLADDER AND KIDNEY CANCER FOLLOWING CYCLOPHOSPHAMIDE THERAPY FOR NON-HODGKINS-LYMPHOMA
Authors: TRAVIS LB CURTIS RE GLIMELIUS B HOLOWAY EJ VANLEEUWEN FE LYNCH CF HAGENBEEK A STOVALL M BANKS PM ADAMI J GOSPODAROWICZ MK WACHOLDER S INSKIP PD TUCKER MA BOICE JD
Citation: Lb. Travis et al., BLADDER AND KIDNEY CANCER FOLLOWING CYCLOPHOSPHAMIDE THERAPY FOR NON-HODGKINS-LYMPHOMA, Journal of the National Cancer Institute, 87(7), 1995, pp. 524-530
ROLES OF RADIOTHERAPY AND SMOKING IN LUNG-CANCER FOLLOWING HODGKINS-DISEASE
Authors: VANLEEUWEN FE KLOKMAN WJ STOVALL M HAGENBEEK A VANDENBELTDUSEBOUT AW NOYON R BOICE JD BURGERS JMV SOMERS R
Citation: Fe. Vanleeuwen et al., ROLES OF RADIOTHERAPY AND SMOKING IN LUNG-CANCER FOLLOWING HODGKINS-DISEASE, Journal of the National Cancer Institute, 87(20), 1995, pp. 1530-1537
POLYCYCLIC AROMATIC HYDROCARBON-DNA ADDUCTS IN WHITE BLOOD-CELL DNA AND 1-HYDROXYPYRENE IN THE URINE FROM ALUMINUM WORKERS - RELATION WITH JOB CATEGORY AND SYNERGISTIC EFFECT OF SMOKING
Authors: VANSCHOOTEN FJ JONGENEELEN FJ HILLEBRAND MJX VANLEEUWEN FE DELOOFF AJA DIJKMANS APG VANROOIJ JGM DENENGELSE L KRIEK E
Citation: Fj. Vanschooten et al., POLYCYCLIC AROMATIC HYDROCARBON-DNA ADDUCTS IN WHITE BLOOD-CELL DNA AND 1-HYDROXYPYRENE IN THE URINE FROM ALUMINUM WORKERS - RELATION WITH JOB CATEGORY AND SYNERGISTIC EFFECT OF SMOKING, Cancer epidemiology, biomarkers & prevention, 4(1), 1995, pp. 69-77
CANCER INCIDENCE IN THE NETHERLANDS IN 1989 AND 1990 - FIRST RESULTS OF THE NATIONWIDE NETHERLANDS CANCER REGISTRY
Authors: VANDERSANDEN GAC COEBERGH JWW SCHOUTEN LJ VISSER O VANLEEUWEN FE
Citation: Gac. Vandersanden et al., CANCER INCIDENCE IN THE NETHERLANDS IN 1989 AND 1990 - FIRST RESULTS OF THE NATIONWIDE NETHERLANDS CANCER REGISTRY, European journal of cancer, 31A(11), 1995, pp. 1822-1829
RISK-FACTORS FOR THE DEVELOPMENT OF ESOPHAGEAL CANCER AS A 2ND PRIMARY TUMOR
Authors: VANHALTEREN HK TAAL BG VANTINTEREN H VANLEEUWEN FE
Citation: Hk. Vanhalteren et al., RISK-FACTORS FOR THE DEVELOPMENT OF ESOPHAGEAL CANCER AS A 2ND PRIMARY TUMOR, European journal of cancer, 31A(11), 1995, pp. 1836-1839
DISSENT - THE RISK OF LUNG-CANCER IN NONSMOKERS IN THE UNITED-STATES - A CAUSAL ASSOCIATION WITH ENVIRONMENTAL TOBACCO-SMOKE
Authors: VANLEEUWEN FE
Citation: Fe. Vanleeuwen, DISSENT - THE RISK OF LUNG-CANCER IN NONSMOKERS IN THE UNITED-STATES - A CAUSAL ASSOCIATION WITH ENVIRONMENTAL TOBACCO-SMOKE, Journal of clinical epidemiology, 48(5), 1995, pp. 599-601
SHOULD TAMOXIFEN BE A PRIMARY-TREATMENT CHOICE FOR ELDERLY BREAST-CANCER PATIENTS WITH LOCOREGIONAL DISEASE
Authors: BERGMAN L VANDONGEN JA VANOOIJEN B VANLEEUWEN FE
Citation: L. Bergman et al., SHOULD TAMOXIFEN BE A PRIMARY-TREATMENT CHOICE FOR ELDERLY BREAST-CANCER PATIENTS WITH LOCOREGIONAL DISEASE, Breast cancer research and treatment, 34(1), 1995, pp. 77-83
P53 PROTEIN OVEREXPRESSION IN RELATION TO RISK-FACTORS FOR BREAST-CANCER
Authors: VANDERKOOY K ROOKUS MA PETERSE JL VANLEEUWEN FE
Citation: K. Vanderkooy et al., P53 PROTEIN OVEREXPRESSION IN RELATION TO RISK-FACTORS FOR BREAST-CANCER, American journal of epidemiology, 141(11), 1995, pp. 31-31
Risultati: 1-25 | 26-40